<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00497016</url>
  </required_header>
  <id_info>
    <org_study_id>HTSTAT</org_study_id>
    <nct_id>NCT00497016</nct_id>
  </id_info>
  <brief_title>Does Statin Therapy Reduce Sympathoexcitation in Hypertension?</brief_title>
  <official_title>Does Statin Therapy Reduce Sympathoexcitation in Hypertension?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <brief_summary>
    <textblock>
      A number of patients with hypertension have increased central sympathetic activity. Statins
      seem to inhibit central sympathetic output. This study assesses the effect of statins on
      central sympathetic activity in hypertension patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in central sympathetic activity</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in cholesterol levels, renin and aldosteron</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">13</enrollment>
  <condition>Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>atorvastatin 80 mg</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  (Known) hypertension

          -  stable drug therapy for at least 2 months

          -  age 18-70 jaar

          -  BMI 18-35 kg/m2

          -  Sinusrhythm

        Exclusion Criteria:

          -  Recent cardiovascular event &lt;6 mnd

          -  Plasma Creatinin:

          -  female: &gt;120 mmol/L

          -  male: &gt;133 mmol/L

          -  use of:

          -  tricyclic antidepressants

          -  alpha-1 -and/or alpha-2 blockers

          -  disease of the autonomic nervous system (Parkinsons disease, Shy- Drager syndrome,
             etc)

          -  Albuminuria &gt;300 mg/dag
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Cees J Tack, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboud University Medical Center Nijmegen</name>
      <address>
        <city>NIjmegen</city>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2007</study_first_submitted>
  <study_first_submitted_qc>July 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2007</study_first_posted>
  <last_update_submitted>September 29, 2008</last_update_submitted>
  <last_update_submitted_qc>September 29, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2008</last_update_posted>
  <keyword>hypertension</keyword>
  <keyword>statin</keyword>
  <keyword>sympathetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin Calcium</mesh_term>
    <mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

